SCHEMBL20073971

SCHEMBL20073971

N#CC1(c2ccc(F)cn2)CCOCCOCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP3K12 Q12852 3/20 0.39
FFAR4 Q5NUL3 1/20 0.37
HDAC6 Q9UBN7 2/20 0.37
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE1C Q14123 1/20 0.36
OPRM1 P35372 8/20 0.33
CYP2D6 P10635 4/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
KCNH2 Q12809 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
PIK3CD O00329 1/20 0.31
ABL1 P00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1760004 0.87 FFAR4 (0.43) FFAR4HDAC6OPRM1KCNH2ALDH1A1
SCHEMBL23008877 0.84 FFAR4 (0.39) MAP3K12FFAR4HDAC6ALDH1A1
SCHEMBL17713182 0.84 FFAR4 (0.39) MAP3K12FFAR4HDAC6ALDH1A1LMNA
SCHEMBL20066130 0.82 FFAR4 (0.38) FFAR4HDAC6OPRM1CYP2D6HDAC3
SCHEMBL29705628 0.80 MAP3K12 (0.37) MAP3K12PDE1APDE1BPDE1CPIK3CD
SCHEMBL21246247 0.80 MAP3K12 (0.37) MAP3K12PDE1APDE1BPDE1COPRM1
SCHEMBL3370369 0.80 MAP3K12 (0.37) MAP3K12PDE1APDE1BPDE1CPIK3CD
SCHEMBL11920960 0.79 FFAR4 (0.39) FFAR4HDAC6
SCHEMBL20074533 0.78 FFAR4 (0.36) MAP3K12FFAR4HDAC6OPRM1
SCHEMBL21246249 0.77 MAP3K12 (0.35) MAP3K12FFAR4PDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069732-A1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LIMITED (GB) 2018-04-19 WO disclosed